litlas
Log inCreate account

Eric L. Matteson

Active 1995–2026

200
Papers
44,659
Citations
108
h-index
193
i10-index

Citations

Citations per year for Eric L. Matteson1978: 4 citations1982: 1 citations1988: 1 citations1996: 4 citations1997: 7 citations1998: 9 citations1999: 9 citations2000: 9 citations2001: 15 citations2002: 17 citations2003: 46 citations2004: 43 citations2005: 65 citations2006: 96 citations2007: 144 citations2008: 166 citations2009: 161 citations2010: 203 citations2011: 193 citations2012: 223 citations2013: 285 citations2014: 258 citations2015: 271 citations2016: 305 citations2017: 367 citations2018: 311 citations2019: 1,402 citations2020: 1,479 citations2021: 1,436 citations2022: 1,096 citations2023: 816 citations2024: 1,221 citations2025: 553 citations2026: 19 citations1979–1981: no citations, so these years are not shown1983–1987: no citations, so these years are not shown1989–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,259 citing papers, 22.1% of this breakdownUnited Kingdom: 1,200 citing papers, 8.1% of this breakdownChina: 1,049 citing papers, 7.1% of this breakdownItaly: 858 citing papers, 5.8% of this breakdownGermany: 727 citing papers, 4.9% of this breakdownFrance: 704 citing papers, 4.8% of this breakdownNetherlands: 571 citing papers, 3.9% of this breakdownCanada: 538 citing papers, 3.6% of this breakdownJapan: 515 citing papers, 3.5% of this breakdownSpain: 488 citing papers, 3.3% of this breakdownAustralia: 343 citing papers, 2.3% of this breakdownSweden: 325 citing papers, 2.2% of this breakdown
0%22.1%Other 28.4%

Institutions

Fields

  • Medicine80.4%
  • Biochemistry, Genetics and Molecular Biology9.2%
  • Immunology and Microbiology6.3%
  • Neuroscience0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Health Professions0.5%
  • Other2.3%

Topics

  • Rheumatoid Arthritis Research and Therapies10.9%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis5.8%
  • Vasculitis and related conditions4.7%
  • Systemic Lupus Erythematosus Research4.3%
  • Systemic Sclerosis and Related Diseases3.6%
  • Spondyloarthritis Studies and Treatments2.9%
  • Other67.8%

Coauthors

All papers

Open in search
  1. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis

    Authors: Jun Chen, Kerry Wright, John M. Davis, Patricio Jeraldo, Eric Marietta, Joseph A. Murray, Heidi Nelson, Eric L. Matteson, Veena Taneja - Genome Medicine 2016 cited by 851

  2. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study

    Authors: Tim Bongartz, Carlotta Nannini, Yimy F. Medina, Sara J. Achenbach, Cynthia S. Crowson, Jay H. Ryu, Robert Vassallo, Sherine E. Gabriel, Eric L. Matteson - Arthritis & Rheumatism 2010 cited by 860

  3. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

    Authors: Pierre‐Antoine Juge, Joyce Lee, Esther Ebstein, Hiroshi Furukawa, Evgenia Dobrinskikh, Steven Gazal, Caroline Kannengiesser, Sébastien Ottaviani, Shomi Oka, Shigeto Tohma, Naoyuki Tsuchiya, Jorge Rojas‐Serrano, Montserrat I. González-Pérez, Mayra Mejía, Ivette Buendía-Roldán, Ramcés Falfán‐Valencia, Enrique Ambrocio-Ortiz, Effrosyni D. Manali, Spyros A. Papiris, T. Karageorgas, Dimitrios T. Boumpas, Κατερίνα Αντωνίου, Coline H.M. van Moorsel, Joanne van der Vis, Yaël A de Man, Jan C. Grutters, Yaping Wang, Raphaël Borie, Lidwine Wémeau-Stervinou, B. Wallaert, René‐Marc Flipo, Hilario Nunès, Dominique Valeyre, Nathalie Saidenberg-Kermanac’h, Marie‐Christophe Boissier, S. Marchand‐Adam, Aline Frazier, Pascal Richette, Yannick Allanore, Jean Sibilia, Claire Dromer, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Nadia Nathan, Serge Amselem, Martin Soubrier, Vincent Cottin, Annick Clément, Kevin D. Deane, Avram Walts, Tasha E. Fingerlin, Aryeh Fischer, Jay H. Ryu, Eric L. Matteson, Timothy B. Niewold, Deborah Assayag, Andrew Gross, Paul J. Wolters, Marvin I. Schwarz, Michael Holers, Joshua J. Solomon, Tracy J. Doyle, Iván O. Rosas, Cornelis Blauwendraat, Mike A. Nalls, Marie‐Pierre Debray, Cathérine Boileau, Bruno Crestani, David A. Schwartz, Philippe Dieudé - New England Journal of Medicine 2018 cited by 502

  4. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

    Authors: Aryeh Fischer, Κατερίνα Αντωνίου, Kevin M. Brown, J. Cadranel, Tamera J. Corte, Roland M. du Bois, Joyce Lee, Kevin O. Leslie, David A. Lynch, Eric L. Matteson, Marta Mosca, Imre Noth, Luca Richeldi, Mary E. Strek, Jeffrey J. Swigris, Athol U. Wells, Sterling G. West, Harold R. Collard, Vincent Cottin - European Respiratory Journal 2015 cited by 1,092

  5. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985–2014

    Authors: Elena Myasoedova, John M. Davis, Eric L. Matteson, Cynthia S. Crowson - Annals of the Rheumatic Diseases 2020 cited by 255

  6. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Authors: Jasvinder A. Singh, Kenneth G. Saag, S. Louis Bridges, Elie A. Akl, Raveendhara R. Bannuru, Matthew C. Sullivan, Elizaveta E. Vaysbrot, Christine McNaughton, Mikala C. Osani, Robert H. Shmerling, Jeffrey R. Curtis, Daniel E. Furst, Deborah Parks, Arthur Kavanaugh, James R. O’Dell, Charles M. King, Amye Leong, Eric L. Matteson, John T. Schousboe, Barbara E. Drevlow, Seth Ginsberg, James Grober, E. William St. Clair, Elizabeth A. Tindall, Amy S. Miller, Timothy E. McAlindon - Arthritis & Rheumatology 2015 cited by 2,787

  7. Methotrexate and rheumatoid arthritis associated interstitial lung disease

    Authors: Pierre‐Antoine Juge, Joyce Lee, Jessica Lau, Letícia Kawano-Dourado, Jorge Rojas‐Serrano, Marco Sebastiani, Gouri Koduri, Eric L. Matteson, Karina Rossi Bonfiglioli, Márcio Valente Yamada Sawamura, Ronaldo Adib Kairalla, Lorenzo Cavagna, Emanuele Bozzalla Cassione, Andreina Manfredi, Mayra Mejía, Pedro Rodríguez‐Henríquez, Montserrat I. González-Pérez, Ramcés Falfán‐Valencia, Ivette Buendía-Roldán, Gloría Pérez-Rubio, Esther Ebstein, Steven Gazal, Raphaël Borie, Sébastien Ottaviani, Caroline Kannengiesser, B. Wallaert, Y. Uzunhan, Hilario Nunès, Dominique Valeyre, Nathalie Saidenberg-Kermanac’h, Marie‐Christophe Boissier, Lidwine Wémeau-Stervinou, René‐Marc Flipo, S. Marchand‐Adam, Pascal Richette, Yannick Allanore, Claire Dromer, Marie‐Elise Truchetet, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Kevin D. Deane, Joshua J. Solomon, Tracy J. Doyle, Jay H. Ryu, Iván O. Rosas, V. Michael Holers, Cathérine Boileau, Marie‐Pierre Debray, Raphaël Porcher, David A. Schwartz, Robert Vassallo, Bruno Crestani, Philippe Dieudé - European Respiratory Journal 2020 cited by 236

  8. Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis

    Authors: Zhen Yang, Yi Shen, Hisashi Oishi, Eric L. Matteson, Lü Tian, Jörg J. Goronzy, Cornelia M. Weyand - Science Translational Medicine 2016 cited by 275

  9. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease

    Authors: Christian Dejaco, Christina Duftner, Frank Buttgereit, Eric L. Matteson, Bhaskar Dasgupta - Lara D. Veeken 2016 cited by 364

  10. Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies

    Authors: Tim Bongartz, Alex J. Sutton, Michael Sweeting, Iain Buchan, Eric L. Matteson, Víctor M. Montori - JAMA 2006 cited by 2,476

  11. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

    Authors: Christian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, Milena Bond, Elvis Hysa, Dario Camellino, Lisa Ehlers, Andy Abril, Simone Appenzeller, María C. Cid, Bhaskar Dasgupta, Christina Duftner, Peter C. Grayson, Bernhard Hellmich, Alojzija Hočevar, Tanaz A. Kermani, Eric L. Matteson, Susan P. Mollan, Lorna Neill, Cristina Ponte, Carlo Salvarani, Sebastian E. Sattui, Wolfgang Schmidt, Philip Seo, Josef S Smolen, Jens Thiel, Carlos Enrique Toro Gutiérrez, Madeline Whitlock, Frank Buttgereit - Annals of the Rheumatic Diseases 2023 cited by 114

  12. Disease stratification in GCA and PMR: state of the art and future perspectives

    Authors: Alessandro Tomelleri, Kornelis S. M. van der Geest, M. Khurshid, Alwin Sebastian, Fiona Coath, Daniel Robbins, Barbara Pierścionek, Christian Dejaco, Eric L. Matteson, Yannick van Sleen, Bhaskar Dasgupta - Nature Reviews Rheumatology 2023 cited by 115

  13. Progressive Decline of Lung Function in Rheumatoid Arthritis–Associated Interstitial Lung Disease

    Authors: Jorge A. Zamora‐Legoff, Megan L. Krause, Cynthia S. Crowson, Jay H. Ryu, Eric L. Matteson - Arthritis & Rheumatology 2016 cited by 220

  14. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease

    Authors: Jie Zhang, Dan Wang, Lei Wang, Shaohua Wang, Anja C. Roden, Hao Zhao, Xiujuan Li, Y. S. Prakash, Eric L. Matteson, Daniel J. Tschumperlin, Robert Vassallo - American Journal of Physiology-Lung Cellular and Molecular Physiology 2019 cited by 200

  15. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases

    Authors: Cynthia S. Crowson, Eric L. Matteson, Elena Myasoedova, Clement J. Michet, Floranne C. Ernste, Kenneth J. Warrington, John M. Davis, Gene G. Hunder, Terry M. Therneau, Sherine E. Gabriel - Arthritis & Rheumatism 2010 cited by 647

  16. The Epidemiology of Antiphospholipid Syndrome: A Population‐Based Study

    Authors: Alí Duarte‐García, Michael M. Pham, Cynthia S. Crowson, Shreyasee Amin, Kevin G. Moder, Rajiv K. Pruthi, Kenneth J. Warrington, Eric L. Matteson - Arthritis & Rheumatology 2019 cited by 285

  17. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

    Authors: Paolo Spagnolo, Oliver Distler, Christopher J. Ryerson, Αrgyris Τzouvelekis, Joyce Lee, Francesco Bonella, Demosthenes Bouros, Anna‐Maria Hoffmann‐Vold, Bruno Crestani, Eric L. Matteson - Annals of the Rheumatic Diseases 2020 cited by 253

  18. Nintedanib in Patients With Autoimmune Disease–Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial

    Authors: Eric L. Matteson, Clive Kelly, Jörg H. W. Distler, Anna‐Maria Hoffmann‐Vold, James R. Seibold, Shikha Mittoo, Paul F. Dellaripa, Martin Aringer, Janet Pope, Oliver Distler, Alexandra James, Rozsa Schlenker‐Herceg, Susanne Stowasser, Manuel Quaresma, Kevin R. Flaherty, the INBUILD Trial Investigators - Arthritis & Rheumatology 2022 cited by 114

  19. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies

    Authors: Patompong Ungprasert, Wisit Cheungpasitporn, Cynthia S. Crowson, Eric L. Matteson - European Journal of Internal Medicine 2015 cited by 318

  20. Polymyalgia Rheumatica and Giant Cell Arteritis

    Authors: Frank Buttgereit, Christian Dejaco, Eric L. Matteson, Bhaskar Dasgupta - JAMA 2016 cited by 488

  21. Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation

    Authors: Gerald Horan, Susan Wood, Victor Ona, Dan Jun Li, Matvey Lukashev, Paul H. Weinreb, Kenneth J. Simon, Kyungmin Hahm, Norm Allaire, Nicola J. Rinaldi, Jaya Goyal, Carol Feghali‐Bostwick, Eric L. Matteson, Carl O’Hara, Robert Lafyatis, Gerald S. Davis, Xiaozhu Huang, Dean Sheppard, Shelia M. Violette - American Journal of Respiratory and Critical Care Medicine 2007 cited by 420

  22. Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study

    Authors: Matthew J. Koster, Cynthia S. Crowson, Rachel Giblon, Jane Jaquith, Alí Duarte‐García, Eric L. Matteson, Cornelia M. Weyand, Kenneth J. Warrington - Annals of the Rheumatic Diseases 2022 cited by 85

  23. Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial

    Authors: Eric L. Matteson, Martin Aringer, Gerd R Burmester, Heiko Mueller, Lizette Moros, Martin Kolb - Clinical Rheumatology 2023 cited by 76

  24. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages

    Authors: Wei Xia, Andrew R. Hilgenbrink, Eric L. Matteson, Michael B Lockwood, Ji‐Xin Cheng, Philip S. Low - Blood 2008 cited by 310